KOLs Interview Series: Dr. Yuan-Hua Ding, Founder & CEO at ATB @InsilicoMedicine
KOLs Interview Series: Dr. Yuan-Hua Ding, Founder & CEO at ATB  @InsilicoMedicine
Uploaded February 2021 | Updated September 2026, 2 weeks ago
Read more about the discovery: insilico.com/blog/pcc
Dr. Yuan-Hua Ding
Founder & CEO at ATB
Former VP & Head of Pfizer Asia Discovery Lab
Drug discovery expert with over 20 years of experience in structural biology
KOLs Interview Series: Dr. Yuan-Hua Ding, Founder & CEO at ATBHow a Drug Candidate for Rare Diseases Could Be the Key to Living LongerScientists Use Virtual Reality to Refine New AI-Generated Drugs for COVID-19Accelerating AI-driven Molecular Modeling with COSMICGenerative Adversarial Networks for Drug Discovery 4x3Insilico Medicines AI-Powered Dancing Robots
Insilico Medicine |

KOLs' Interview Series: Dr. Yuan-Hua Ding, Founder & CEO at ATB

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER